Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| depot medroxyprogesterone acetate | Active Comparator |
| |
| No depot medroxyprogesterone acetate | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| depot medroxyprogesterone acetate | Drug | DMPA 150 mg intramuscular Before surgery 3 months (plus or minus 2 weeks) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage Changes of Serum Anti-Mullerian Hormone (AMH) at 2-week and 3-month Post Operation | Within the first 2 weeks and 3 months after surgery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Oral contraceptives, GnRH analogues, Progestins, Danazol
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Obstetrics and Gynecology | Ratchathewi | Bangkok | 10400 | Thailand |
Assessed for eligibility n=60 Excluded n=20 (15=not compatible with inclusion criteria 5=denied to participate)
Mar.2012-Feb.2013 University Hospital
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | No Depot Medroxyprogesterone Acetate | |
| FG001 | Depot Medroxyprogesterone Acetate | depot medroxyprogesterone acetate : DMPA 150 mg intramuscular Before surgery 3 months (plus or minus 2 weeks) |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| COMPLETED |
|
| NOT COMPLETED |
|
|
Lost follow up total 6 patients
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | No Depot Medroxyprogesterone Acetate | |
| BG001 | Depot Medroxyprogesterone Acetate | depot medroxyprogesterone acetate : DMPA 150 mg intramuscular Before surgery 3 months (plus or minus 2 weeks) |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants | Participants |
| ||||||||||||||||||
| Age Continuous | Mean | Standard Deviation | years |
| |||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||||
| Region of Enrollment | Number | participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Percentage Changes of Serum Anti-Mullerian Hormone (AMH) at 2-week and 3-month Post Operation | Posted | Median | Inter-Quartile Range | percentage of serum AMH change | Within the first 2 weeks and 3 months after surgery |
|
|
|
Not provided
serious and/or other [non-serious] adverse events were not collected/assessed
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | DMPA | 0 | 0 | 0 | 0 |
Not provided
Not provided
Small sample size
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Weena Krutsawad | Mahidol University | 66812070264 | vna_fe2@hotmail.com |
| ID | Term |
|---|---|
| D004715 | Endometriosis |
| ID | Term |
|---|---|
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
Not provided
Not provided
| >=65 years |
|
| Male |
|